XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
24.14
-0.09 (-0.37%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Company Description

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific.

It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates.

The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.

It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024.

XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMA Royalty Corporation
XOMA Royalty logo
Country United States
Founded 1981
Industry Biotechnology
Sector Healthcare
Employees 13
CEO Owen Hughes

Contact Details

Address:
2200 Powell Street, Suite 310
Emeryville, California 94608
United States
Phone 510 204 7200
Website xoma.com

Stock Details

Ticker Symbol XOMA
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000791908
CUSIP Number 98419J206
ISIN Number US98419J2069
Employer ID 52-2154066
SIC Code 2834

Key Executives

Name Position
Owen P. Hughes Jr. Chief Executive Officer and Director
Thomas M. Burns Senior Vice President of Finance and Chief Financial Officer

Latest SEC Filings

Date Type Title
Apr 15, 2025 ARS Filing
Apr 15, 2025 DEF 14A Other definitive proxy statements
Apr 4, 2025 PRE 14A Other preliminary proxy statements
Mar 17, 2025 10-K Annual Report
Mar 17, 2025 8-K Current Report
Feb 11, 2025 8-K/A [Amend] Current report
Jan 28, 2025 SCHEDULE 13D/A Filing
Dec 2, 2024 8-K Current Report
Nov 7, 2024 8-K Current Report
Nov 7, 2024 10-Q Quarterly Report